AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma-Reference-Cited by-同舟云学术

AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma

Published:2017-08 Issue:8 Volume:187 Page:1700-1716
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Wang Jinfen,Xu-Monette Zijun Y.,Jabbar Kausar J.,Shen Qi,Manyam Ganiraju C.,Tzankov Alexandar,Visco Carlo,Wang Jing,Montes-Moreno Santiago,Dybkær Karen,Tam Wayne,Bhagat Govind^ORCID,Hsi Eric D.,van Krieken J. Han,Ponzoni Maurilio,Ferreri Andrés J.M.,Wang Shi,Møller Michael B.^ORCID,Piris Miguel A.,Medeiros L. Jeffrey^ORCID,Li Yong,Pham Lan V.,Young Ken H.

Funder

National Cancer Institute

MD Anderson Cancer Center

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference53 articles.

1. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling;Alizadeh;Nature,2000

2. The biology of human lymphoid malignancies revealed by gene expression profiling;Staudt;Adv Immunol,2005

3. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray;Hans;Blood,2004

4. Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

5. PI3K/Akt and apoptosis: size matters;Franke;Oncogene,2003

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of the Protein Kinase B (PKB) Gene on the Carcinogenesis of Oral Squamous Cell Carcinoma in the South Indian Population;Cureus;2024-05-11

2. SYNTHESIS, IN SILICO STUDY AND ANTITUMOR ACTIVITY OF COUMARIN COMPOUNDS IN LYMPHOMA CELLS;FARMACIA;2023-12-28

3. SARS-CoV-2 activates the TLR4/MyD88 pathway in human macrophages: A possible correlation with strong pro-inflammatory responses in severe COVID-19;Heliyon;2023-11

4. B cell receptor activation: molecular mechanisms and therapeutic targets;HEMATOLOGIE;2023

5. Pharmacologic Differentiation of Drugs Targeting the PI 3K‐ AKT ‐m TOR Signaling Pathway;Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies;2023-03-15